These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


147 related items for PubMed ID: 6230003

  • 1. Mycosis fungoides/Sezary's syndrome progressing to immunoblastic sarcoma. A T-cell lymphoproliferation with both helper and suppressor phenotypes.
    Yanagihara ET, Parker JW, Meyer PR, Cain MJ, Hofman F, Lukes RJ.
    Am J Clin Pathol; 1984 Feb; 81(2):249-57. PubMed ID: 6230003
    [Abstract] [Full Text] [Related]

  • 2. Immunohistochemical studies using monoclonal antibodies on lymph nodes from patients with mycosis fungoides and Sézary's syndrome.
    Willemze R, Scheffer E, Meijer CJ.
    Am J Pathol; 1985 Jul; 120(1):46-54. PubMed ID: 3893151
    [Abstract] [Full Text] [Related]

  • 3. Immunopathology of non-Hodgkin lymphomas.
    Huber H, Gattringer C, Knapp W, Stein H.
    Klin Wochenschr; 1984 Nov 02; 62(21):1001-10. PubMed ID: 6392723
    [Abstract] [Full Text] [Related]

  • 4. Demonstration of a subpopulation of Ia+ T-helper cells in mycosis fungoides and the Sézary syndrome.
    Hofman FM, Meyer PR, Yanagihara E, Modlin RL, Rea TH, Parker JW, Lukes RJ, Taylor CR.
    Am J Dermatopathol; 1983 Apr 02; 5(2):135-43. PubMed ID: 6224436
    [Abstract] [Full Text] [Related]

  • 5. T cell subset heterogeneity in a series of patients with mycosis fungoides and Sézary syndrome.
    Piepkorn M, Marty J, Kjeldsberg CR.
    J Am Acad Dermatol; 1984 Sep 02; 11(3):427-32. PubMed ID: 6237132
    [Abstract] [Full Text] [Related]

  • 6. Cutaneous T-cell lymphoma in association with a monoclonal gammopathy.
    Joyner MV, Cassuto JP, Dujardin P, Barety M, Duplay H, Audoly P.
    Arch Dermatol; 1979 Mar 02; 115(3):326-8. PubMed ID: 107864
    [Abstract] [Full Text] [Related]

  • 7. Use of monoclonal antibodies specific for T cell subsets in cutaneous disorders: I. Quantitative analysis of peripheral blood lymphocytes.
    Faure M, Thivolet J.
    J Clin Immunol; 1982 Jul 02; 2(3 Suppl):103S-110S. PubMed ID: 6215423
    [Abstract] [Full Text] [Related]

  • 8. OKT 9 reactivity in mycosis fungoides and large plaque (atrophic) parapsoriasis.
    McMillan EM, Wasik R, Peters S, Jackson I, Stoneking L, Everett MA.
    Cancer; 1983 Apr 15; 51(8):1403-7. PubMed ID: 6337701
    [Abstract] [Full Text] [Related]

  • 9. Surface markers and mitogen response of cells harvested from cutaneous infiltrates in mycosis fungoides and Sézary's syndrome.
    Burg G, Rodt H, Grosse-Wilde H, Braun-Falco O.
    J Invest Dermatol; 1978 May 15; 70(5):257-9. PubMed ID: 147911
    [Abstract] [Full Text] [Related]

  • 10. Radiosensitivity of the helper function of a Sezary lymphocyte population.
    Campos A, de la Concha EG, Brieva JA, Arrazola JM, Bootello A.
    Clin Immunol Immunopathol; 1982 Aug 15; 24(2):292-6. PubMed ID: 6214357
    [No Abstract] [Full Text] [Related]

  • 11. Morphologic and immunologic characterization of 50 peripheral T-cell lymphomas.
    Weiss LM, Crabtree GS, Rouse RV, Warnke RA.
    Am J Pathol; 1985 Feb 15; 118(2):316-24. PubMed ID: 3155915
    [Abstract] [Full Text] [Related]

  • 12. Cerebriform (Sézary like) mononuclear cells in healthy individuals: a morphologically distinct population of T cells. Relationship with mycosis fungoides and Sézary's syndrome.
    Meyer CJ, van Leeuwen AW, van der Loo EM, van de Putte LB, van Vloten WA.
    Virchows Arch B Cell Pathol; 1977 Oct 27; 25(2):95-104. PubMed ID: 145087
    [Abstract] [Full Text] [Related]

  • 13. Dermatopathic lymphadenopathy. An immunophenotypic comparison of cases associated and unassociated with mycosis fungoides.
    Burke JS, Sheibani K, Rappaport H.
    Am J Pathol; 1986 May 27; 123(2):256-63. PubMed ID: 3486598
    [Abstract] [Full Text] [Related]

  • 14. T cells in cutaneous lesions of Sézary syndrome and T-cell leukemia. Characterization by monoclonal antibodies.
    Buechner SA, Winkelmann RK, Banks PM.
    Arch Dermatol; 1983 Nov 27; 119(11):895-900. PubMed ID: 6227293
    [Abstract] [Full Text] [Related]

  • 15. Cytologic evaluation of lymphadenopathy associated with mycosis fungoides and Sezary syndrome: role of immunophenotypic and molecular ancillary studies.
    Pai RK, Mullins FM, Kim YH, Kong CS.
    Cancer; 2008 Oct 25; 114(5):323-32. PubMed ID: 18798522
    [Abstract] [Full Text] [Related]

  • 16. Cutaneous T-cell lymphoma: a review.
    Winkler CF, Bunn PA.
    Crit Rev Oncol Hematol; 1983 Oct 25; 1(1):49-92. PubMed ID: 6083835
    [Abstract] [Full Text] [Related]

  • 17. High-grade malignant lymphoma arising from Sézary's syndrome. A case report.
    Kienitz T, Burg G, Schmoeckel C, Weitz H, Braun-Falco O.
    Dermatologica; 1979 Oct 25; 158(2):126-36. PubMed ID: 761696
    [Abstract] [Full Text] [Related]

  • 18. In situ immunologic phenotyping of mycosis fungoides.
    McMillan EM, Wasik R, Beeman K, Everett MA.
    J Am Acad Dermatol; 1982 May 25; 6(5):888-97. PubMed ID: 7047586
    [Abstract] [Full Text] [Related]

  • 19. Upregulation of inhibitory signaling receptor programmed death marker-1 (PD-1) in disease evolution from cutaneous lymphoid dyscrasias to mycosis fungoides and Sezary's syndrome.
    Nguyen GH, Olson LC, Magro CM.
    Ann Diagn Pathol; 2017 Jun 25; 28():54-59. PubMed ID: 28648940
    [Abstract] [Full Text] [Related]

  • 20. Immunohistochemical analysis of mycosis fungoides on paraffin-embedded tissue sections.
    Izban KF, Hsi ED, Alkan S.
    Mod Pathol; 1998 Oct 25; 11(10):978-82. PubMed ID: 9796726
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.